Fagron SA (GB:0HNZ) has released an update.
Fagron has concluded its share repurchase program, acquiring 150,000 shares at an average of €19.06 each, totaling €2,859,102.43. This recent batch of 45,000 shares was bought for €859,324.10, to fulfill the obligations of the company’s variable compensation scheme. The multinational pharmaceutical company specializes in personalized medicine, operating in over 30 countries.
For further insights into GB:0HNZ stock, check out TipRanks’ Stock Analysis page.
